Liver metastases from colorectal cancer: A multidisciplinary approach is necessary;Métastases hépatiques des cancers colorectaux: La prise en charge multidisciplinaire est indispensable

Bulletin de l'Academie Nationale de Medecine

Volumn 192, Issue 1, 2008, Pages 33-44

  Nordlinger, Bernard ^a   Benoist, Stéphane ^a  

^a HÔPITAL AMBROISE PARÉ   (France)

Author keywords

Colorectal neoplasms; Drug therapy; Liver neoplasms; Neoplasms metastasis; Surgery

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; COLORECTAL TUMOR; HUMAN; LIVER TUMOR; METASTASIS; PATHOLOGY; PATIENT CARE; REVIEW;

CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; HUMANS; LIVER NEOPLASMS; NEOADJUVANT THERAPY; PATIENT CARE TEAM;

EID: 54049136992     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)32866-3     Document Type: Article

References (45)

1. [1] TRUANT S., OBERLIN O., SERGENT G., et al. - Remnant liver volume to body weight ratio > or = 0.5 % : A new cut - off to estimate postoperative risks after extended resection in noncirrhotic liver. J. Am. Coll. Surg., 2007, 204, 22-33. (Pubitemid 44960031)
2. [2] THALER K., KANNEGANTI S., KHAJANCHEE Y., et al. - The evolving role of staging laparoscopy in the treatment of colorectal hepatic metastasis. Arch. Surg., 2005, 140, 727-734. (Pubitemid 41175696)
3. NORDLINGER B., JAECK D., GUIGUET M., et al. - Surgical resection of hepatic metastases. Multicentric retrospective study by the French Association of Surgery. In Treatment of hepatic metastases of colorectal cancer (Edition Paris, Springer-Verlag), 1992.
4. [4] JAECK D. - The significance of hepatic pedicle lymph nodes metastases in surgical manage- ment of colorectal liver metastases and of other liver malignancies. Ann. Surg. Oncol., 2003, 10, 1007-1011. (Pubitemid 40486822)
5. [5] ZACHERL J., SCHEUBA C., IMHOF N., et al. - Current value of intraoperative sonography during surgery for hepatic neoplasms. World J. Surg., 2002, 26, 550-554. (Pubitemid 36920365)
6. [6] FINCH R., MALIK H., HAMADY Z., et al. - Effect of type of resection on outcome of hepatic resection for colorectal metastases. Br. J Surg. 2007., 94, 1242-1248. (Pubitemid 47584773)
7. [7] WEBER J.C., BACHELLIER P., OUSSOULTZOGLOU E., JAECK D. - Simultaneous resection of colorectal primary tumour and synchronous liver metastases. Br. J. Surg., 2003, 90, 956-962. (Pubitemid 37026324)
8. [8] ALLEN P.J., KEMENY N., JARNAGIN W. et al. - Importance of response to neoajuvant chemo-therapy in patients undergoing resection of synchronous colorectal liver metastases. J. Gastrointest.Surg., 2003, 7, 109-115. (Pubitemid 36875808)
9. [9] NORDLINGER B., QUILICHINI M.A., PARC R., HANNOUN L., DEL VA E., HUGUET C. - Hepatic resection for colorectal liver metastases. Influence on survival of preoperative factors and surgery for recurrence in 80 patients. Ann. Surg., 1987, 205, 256-263. (Pubitemid 17037048)
10. DOCI R., GERMAN L., BIGMANI P., MONTALLO F., MORANITO A., BOZZETTI F. - One hundred patients with hepatic metastases from colorectal cancer treated by resection : analysis of prognostic determinant. Br. J. Surg., 1991, 78, 797-801.
11. SCHEELE J., STANG R., ALTENDORF-HOFMANNA, PAUL M. - Resection of colorectal liver metastases. World J. Surg., 1995, 19, 59-71.
12. [12] JAMISON R.L., DONOHUE J.H., NAGORNEY D.M. et al. - Hepatic resections for metastatic colorectal cancer. Results in cure for some patients. Arch. Surg., 1997, 132, 505-511. (Pubitemid 27215091)
13. FONG Y., FORTNER J., SUN R.L., BRENNAN M.F., BLUMGART L.H. -Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer : analysis of 1001 consecutive cases. Ann. Surg., 1999, 230, 309-318.
14. MINAGAWA M., MAKUUCHI M., TORZILLI G. et al. - Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer. Ann. Surg., 2000, 231, 487-499.
15. ERCOLANI G., GRAZI G.L., RAVAIOLI M., et al. - Liver resection for multiple colorectal metastases : influence of parenchymal involvement and total tumor volume, vs number or location, on long-term survival. Arch. Surg., 2002, 137, 1187-1192.
16. CHOTI M.A., SITZMANN J.V., TIBURI M.F., et al. - Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann. Surg., 2002, 235, 759-766.
17. PAWLIK T.M., SCOGGINS C.R., ZORZI D., et al. - Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann. Surg., 2005, 241, 715-722.
18. NORDLINGER B., GUIGUET M., VAILLANT J-C. et al. - Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Cancer, 1996, 77, 1254-1262.
19. NORDLINGER B., VAILLANT J.C., GUIGUET P., et al. - Repeat liver resections for recurrent colorectal metastases : Prolonged survivals. J. Clin. Oncol., 1994, 12, 1491-1496.
20. ADAM R., PASCAL G., AZOULAY D., et al. - Liver resection for colorectal metastases : the third hepatectomy. Ann. Surg., 2003, 238, 871-883.
21. LORENZ M., MULLER H.H., SHRAMM H. et al. -Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. Ann. Surg., 1998, 228, 756-762.
22. KEMENY N., HUANG Y., COHEN A. et al. - Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N. Engl. J. Med., 1999, 341, 2039-2048.
23. KEMENY M.M., SUDESHNA A., GRAY B. et al. - Combined modality treatment for resectable metastatic colorectal carcinoma to the liver : surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy. J. Clin. Oncol., 2002, 20, 1499-1505.
24. PORTIER G., ELIAS D., BOUCHE O., et al. - Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases : FFCD ACHBTH AURC 9002 trial. J. Clin. Oncol., 2006, 24, 4976-4982.
25. LANGER B., BLEIBERG H., LABIANCA R. et al. -Fluorouracil (FU) plus 1-leucovorin (1-LV) versus observation after potentially curative resection of liver or lung metastases from colorectal cancer (CRC) : results of the ENG (EORTC/NCIC CTG/GIVIO) randomized trial. J. Clin. Oncol., 2002, 20, 592.
26. E. MITRY, A. FIELDS, H. BLEIBERG, R. et al. - Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer. A meta-analysis of two randomized trials. J. Clin. Oncol. 2006, 24, 3524.
27. ADAM R., PASCAL G., CASTAING D., et al. - Tumor progression while on chemotherapy : a contraindication to liver resection for multiple colorectal metastases ? Ann. Surg., 2004, 240, 1052-1061.
28. WEIN A., RIEDEL C., BRUCKL W., et al. - Neoadjuvant treatment with weekly high-dose 5-Fluorouracil as 24-hour infusion, folinic acid and oxaliplatin in patients with primary resectable liver metastases of colorectal cancer. Oncology, 2003, 64, 131-138.
29. TAIEB J., ARTRU P., PAYÉ F., et al. -Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer : results of a phase II study. J. Clin. Oncol., 2005, 23, 502-509.
30. NORDLINGER B., SORBYE H., COLLETTE L. et al. - Final results of the EORTC intergroup randomized phase III study 40983 [EPOC] evaluating the benefit of peri- operative FOLFOX4 chemotherapy for patients with potentially resectable colorectal liver metastases. J. Clin. Oncol., 2007, 25, LBA5.
31. BENOIST S., BROUQUET A., PENNA C., et al. - Complete response of colorectal liver metastases after chemotherapy : does it mean cure ? J. Clin. Oncol., 2006, 24, 3939-3945.
32. KAROUI M., PENNA C., AMIN-HASHEM M., et al. - Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann. Surg., 2006, 243, 1-7.
33. VAUTHEY J.N., PAWLIK T.M., RIBERO D., et al. - Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J. Clin. Oncol. 2006, 24, 2065-2072.
34. ALOIA T., SEBAGH M., PLASSE M., et al. - Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J. Clin. Oncol., 2006, 24, 4983-4990.
35. NORDLINGER B., BENOIST S. - Benefits and risks of neoadjuvant therapy for liver metastases. J. Clin. Oncol, 2006, 24, 4954-4955.
36. RUBBIA-BRANDT L., AUDARD V., SARTORETTI P., et al. - Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann. Oncol, 2004, 15, 460-466.
37. OUSSOULTZOGLOU E.,BACHELLUR P., Rosso E., et al. - Right portal vein embolization before right hepatectomy for unilobar colorectal liver metastases reduces the intrahepatic recurrence rate. Ann. Surg., 2006, 244, 71-79.
38. KORNPRAT P., JARNAGIN W.R., DEMATTEO R.P., et al. - Role of intraoperative thermoablation combined with resection in the treatment of hepatic metastasis from colorectal cancer. Arch. Surg., 2007, 142, 1087-1092.
39. ADAM R., DELVART V., PASCAL G. et al. - Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy : a model to predict long-term survival. Ann. Surg., 2004, 240, 644-657.
40. MASI G., CUPINI S., MARCUCCI L., et al. - Treatment with 5- fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer. Ann. Surg. Oncol., 2006, 13, 58-65.
41. MERIC F., PATT Y.Z., CURLEY S.A., et al. - Surgery after downstaging of unresectable hepatic tumors with intra-arterial chemotherapy. Ann. Surg. Oncol., 2000, 7,490-1195
42. KEMENY N., JARNAGIN W., PATY P., et al. - Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. J. Clin. Oncol., 2005, 23, 4888-4896.
43. ROUGIER P., RAOUL J., VAN LAETHEM J., et al. - Cetuximab + FOLFIRI as first-line treatment for metastatic colorectal cancer. J. Clin. Oncol., 2004, 22, 248s.
44. FISCHER G.A., Kuo T., CHO C., et al. - A phase II study of gefitinib in combination with FOLFOX-4 in patients with metastatic colorectal cancer. J. Clin. Oncol., 2004, 22, 248s.
45. ADAM R., ALOIA T., LEVI F., et al. - Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy. J. Clin. Oncol., 2007, 25, 4593-4602.